Literature DB >> 3338817

Rate of incorporation of radiolabelled nucleosides does not necessarily reflect the metabolic state of cells in culture: effects of latent mycoplasma contamination.

M Merkenschlager1, D Kardamakis, F C Rawle, N Spurr, P C Beverley.   

Abstract

In response to cell-free conditioned medium derived from the human bladder carcinoma line T24 (T24 SN), we found greatly reduced incorporation of tritiated thymidine and uridine ([3H]TdR, [3H]UR) by the human carcinoma lines UCHNCu (small-cell lung carcinoma) and LS174T (colon carcinoma). The effect was not due to an excess of nucleosides or cytokines known to be present in T24 SN. Cell-cycle distribution, increase in cell numbers, and de novo nucleoside synthesis in the indicator cells were only slightly altered. This was in contrast to the gross reduction in [3H]TdR/[3H]UR incorporation and seemed to indicate selective downregulation of pyrimidine-salvage pathways, despite ongoing polynucleotide synthesis. Spontaneous [3H]TdR uptake remained low for several passages in vitro but was readily restored by pharmacological inhibition of de novo pathways with 5-fluoro-deoxy-uridine (5-FUdR). This suggested a stable but reversible regulatory effect of T24 SN on the pyrimidine metabolism of the indicator cells. Further investigation showed degradation of [3H]TdR by a particle-bound activity in T24 SN. Mycoplasma contamination of T24 had not been detectable using standard cultural and staining methods, but became apparent when T24-cell lysates were hybridized with a recently described DNA probe (Goebel & Stanbridge, 1984). We conclude that latent mycoplasma contamination can stimulate changes in cellular pyrimidine metabolism. Our results provide an example for latent mycoplasma infection mimicking metabolic changes in cultured cells by direct interference of a microbial enzyme with the assay system. We describe a rapid and simple bioassay to detect and distinguish particle-associated and soluble phosphorylase activity by [3H]TdR degradation. It may be a useful screening assay for mycoplasma contamination in tissue culture.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3338817      PMCID: PMC1454707     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  35 in total

1.  Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor.

Authors:  R F Tucker; G D Shipley; H L Moses; R W Holley
Journal:  Science       Date:  1984-11-09       Impact factor: 47.728

2.  Inhibition of cell division by interferons. The relationship between changes in utilization of thymidine for DNA synthesis and control of proliferation in Daudi cells.

Authors:  D R Gewert; G Moore; M J Clemens
Journal:  Biochem J       Date:  1983-09-15       Impact factor: 3.857

3.  Induction of thymidine kinase in enzyme-deficient Chinese hamster cells.

Authors:  M Harris
Journal:  Cell       Date:  1982-06       Impact factor: 41.582

4.  Mycoplasma infection of cell cultures: thymidine incorporation of culture supernatants as a screening test.

Authors:  D R Kaplan; T J Henkel; V Braciale; T J Braciale
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

5.  "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

6.  Purification and initial characterization of a type beta transforming growth factor from human placenta.

Authors:  C A Frolik; L L Dart; C A Meyers; D M Smith; M B Sporn
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

7.  Mitogenicity and pathogenicity of Mycoplasma pulmonis in rats. I. Atypical interstitial pneumonia induced by mitogenic myeoplasmal membranes.

Authors:  Y Naot; S Davidson; E S Lindenbaum
Journal:  J Infect Dis       Date:  1981-01       Impact factor: 5.226

8.  Mycoplasma contamination in human tumor cell lines: effect on interferon induction and susceptibility to natural killing.

Authors:  C Birke; H H Peter; U Langenberg; W J Müller-Hermes; J H Peters; J Heitmann; W Leibold; H Dallügge; E Krapf; H Kirchner
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

9.  Adenosine phosphorylase activity in mycoplasma-free growth media for mammalian cells.

Authors:  V Verhoef; G Germain; A Fridland
Journal:  Exp Cell Res       Date:  1983-11       Impact factor: 3.905

10.  Uridine uptake inhibition as a cytotoxicity test: correlations with the Draize test.

Authors:  C Shopsis; S Sathe
Journal:  Toxicology       Date:  1984-01       Impact factor: 4.221

View more
  3 in total

1.  Nucleoside-catabolizing enzymes in mycoplasma-infected tumor cell cultures compromise the cytostatic activity of the anticancer drug gemcitabine.

Authors:  Johan Vande Voorde; Suna Sabuncuoğlu; Sam Noppen; Anders Hofer; Farahnaz Ranjbarian; Steffen Fieuws; Jan Balzarini; Sandra Liekens
Journal:  J Biol Chem       Date:  2014-03-25       Impact factor: 5.157

2.  Mycoplasma contamination revisited: mesenchymal stromal cells harboring Mycoplasma hyorhinis potently inhibit lymphocyte proliferation in vitro.

Authors:  Severin Zinöcker; Meng-Yu Wang; Peter Gaustad; Gunnar Kvalheim; Bent Rolstad; John T Vaage
Journal:  PLoS One       Date:  2011-01-11       Impact factor: 3.240

Review 3.  Mycoplasmas and cancer: focus on nucleoside metabolism.

Authors:  Johan Vande Voorde; Jan Balzarini; Sandra Liekens
Journal:  EXCLI J       Date:  2014-03-27       Impact factor: 4.068

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.